Nanomaterials for alternative antibacterial therapy.

Area of Science:

• Materials Science
• Microbiology
• Nanotechnology
• Pharmacology

Background:

• Bacterial infections, particularly nosocomial ones, cause significant global morbidity and mortality.
• Multidrug resistance and biofilm-associated infections present major clinical challenges.
• Existing antibiotics have limitations including toxicity and diminishing efficacy against resistant strains.

Purpose of the Study:

• To review the challenges posed by multidrug-resistant bacterial infections.
• To explore the potential of nanomaterials, specifically metal-based nanoparticles, as antibacterial agents.
• To discuss novel therapeutic strategies for combating severe bacterial infections.

Main Methods:

• Review of existing literature on multidrug resistance and bacterial evasion mechanisms.
• Analysis of the antibacterial mechanisms of metal and metal oxide nanoparticles (NPs).
• Investigation of polymer-based nanomaterials and nanocomposites for antimicrobial applications.

Main Results:

• Metal and metal oxide NPs exhibit microbicidal and microbiostatic effects.
• Nanomaterials can overcome bacterial resistance and biofilm challenges.
• Polymer-based nanomaterials and nanocomposites show promise as alternative antimicrobial agents.

Conclusions:

• Nanomedicines, particularly metal-based NPs, are vital in combating antimicrobial resistance.
• Combinatorial therapy with metallic NPs can enhance existing antibiotic treatments.
• Developing novel nanomaterial-based strategies is crucial for addressing severe bacterial infections.